Maria Vazquez-Gragg, MD, a pediatric surgeon with over 19 years of clinical, drug safety, regulatory and pharmacovigilance experience in the pharmaceutical industry, recently joined RTI Health Solutions (RTI-HS) as Global Head of Safety and Pharmacovigilance.
Prior to RTI-HS, Dr. Vazquez-Gragg worked at the regulatory affairs department at Merck, where she was responsible for safety and regulatory activities. Following this, she held positions in the areas of clinical, drug safety and pharmacovigilance throughout her career, including Wyeth and Johnson & Johnson. Most recently she has been a medical director at PAREXEL International where she directed pharmacovigilance activities.
"With her astute leadership skills, broad industry expertise, and impeccable credentials, Maria is uniquely qualified to lead our diverse and growing safety and pharamacovigilance business” said Dr. Allen Mangel, RTI-HS Executive Vice President. "I welcome her to the RTI-HS senior leadership team."
Dr. Maria Vazquez-Gragg earned her medical degree from Universidad de Buenos Aires, Argentina. Dr. Vazquez-Gragg has authored numerous articles on a wide array of topics, including pharmacovigilance and risk management and has given several presentations at biopharmaceutical industry conferences, as well as at meetings held by industry regulators.
“I am excited to lead a distinguished group of medical safety experts and work for an organization that demonstrates an unwavering commitment to high standards, integrity and quality of work products for our clients”, said Maria.
About RTI Health Solutions
RTI Health Solutions provides scientifically rigorous research and consulting service in health economics, health outcomes, psychometrics, market access, health preference assessment, epidemiology, pharmacovigilance, clinical development, and biostatistics to help biopharmaceutical companies successfully develop and gain market approval for their products.